0001140361-24-041427.txt : 20240918
0001140361-24-041427.hdr.sgml : 20240918
20240918210112
ACCESSION NUMBER: 0001140361-24-041427
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240917
FILED AS OF DATE: 20240918
DATE AS OF CHANGE: 20240918
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LASERSOHN JACK W
CENTRAL INDEX KEY: 0001083925
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38847
FILM NUMBER: 241308666
MAIL ADDRESS:
STREET 1: 18 BANK STREET
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Silk Road Medical Inc
CENTRAL INDEX KEY: 0001397702
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 208777622
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1213 INNSBRUCK DR.
CITY: SUNNYVALE
STATE: CA
ZIP: 94089-2918
BUSINESS PHONE: 6505669060
MAIL ADDRESS:
STREET 1: 1213 INNSBRUCK DR.
CITY: SUNNYVALE
STATE: CA
ZIP: 94089-2918
4
1
form4.xml
FORM 4
X0508
4
2024-09-17
true
0001397702
Silk Road Medical Inc
SILK
0001083925
LASERSOHN JACK W
1213 INNSBRUCK DRIVE
SUNNYVALE
CA
94089
true
false
Common Stock
2024-09-17
4
D
0
16735
D
0
D
Stock Option (right to buy)
20
2024-09-17
4
D
0
8910
7.5
D
2029-04-03
Common Stock
8910
0
D
Of the reported shares, 5,859 are represented by restricted stock units, or RSUs, each of which represents a contingent right to receive one share of Issuer common stock.
Pursuant to the Agreement and Plan of Merger dated June 17, 2024, between the Issuer, Boston Scientific Corporation and Seminole Merger Sub, Inc, (the "Merger Agreement"), each share of Issuer common stock was canceled and converted into the right to receive $27.50 per share in cash (the "Merger Consideration"), without interest and subject to applicable withholding taxes.
Pursuant to the Merger Agreement, each RSU was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the Merger Consideration and (ii) the aggregate number of shares underlying the RSUs, less applicable taxes and authorized deductions.
The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $66,825.00, which represents the difference between (i) the amount by which the Merger Consideration exceeded the exercise price of the option per share option and (ii) the aggregate number of shares remaining issuable upon exercise of the option, less applicable taxes and authorized deductions.
/s/ Mhairi Jones, by power of attorney
2024-09-18